Yellowstone Partners’s AbbVie ABBV Stock Holding History

Yellowstone Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.14M	Sell	11,804 -1,096	-8%	-$103K	0.65%	36
2017 Q3	$1.15M	Buy	+12,900	New	+$982K	0.6%	39
2016 Q3	$876K	Sell	13,894 -102	-0.7%	-$6.6K	0.32%	82
2016 Q2	$866K	Sell	13,996 -833	-6%	-$50.8K	0.37%	76
2016 Q1	$847K	Sell	14,829 -2,600	-15%	-$145K	0.36%	68
2015 Q4	$1.03M	Buy	17,429 +2,713	+18%	+$156K	0.46%	44
2015 Q3	$801K	Buy	14,716 +3,886	+36%	+$253K	0.38%	51
2015 Q2	$728K	Buy	10,830 +4,834	+81%	+$316K	0.33%	55
2015 Q1	$351K	Buy	5,996 +2,247	+60%	+$136K	0.18%	108
2014 Q4	$245K	Buy	+3,749	New	+$236K	0.13%	142

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Yellowstone Partners's ABBV Position: Q4 2017 in Review

Yellowstone Partners reduced its AbbVie (ABBV) stake by 8.5% in Q4 2017, selling an estimated $103K and leaving 11,804 shares worth $1.14M. The position accounts for 0.65% of the portfolio, ranked #36.

Yellowstone Partners first reported a position in ABBV in Q4 2014 and has held it in 10 quarters since. The position peaked at $1.15M in Q3 2017. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

Yellowstone Partners held 11,804 shares of AbbVie worth $1.14M as of Q4 2017.
Yellowstone Partners sold 1,096 AbbVie shares in Q4 2017, an estimated $103K.
AbbVie made up 0.65% of Yellowstone Partners's portfolio in Q4 2017, its #36 holding.
Yellowstone Partners first reported a position in AbbVie in Q4 2014 and has held it in 10 quarters since.
Yellowstone Partners's AbbVie position peaked at $1.15M in Q3 2017.
2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.